Diabetes Board decisions

The Board denied service connection for type II diabetes, peripheral neuropathy of the bilateral upper and lower extremities, GERD, liver cancer, heart disability, skin cancer, sinusitis, and a heart disability on the basis that there was no evidence to support an in-service incurrence or continuity of symptomatology since service.

The Board denied service connection for diabetes mellitus type II, hypertension, and hypothyroidism prior to August 10, 2022, but granted a 10 percent rating for painful scars of the bilateral knees.

The Board denied service connection for the cause of the Veteran's death, as there was no evidence that the Veteran was exposed to herbicide agents during his service or that his T-cell lymphoma, DM, and hypertension were caused by any incident of service.

The Board granted service connection for diabetes mellitus type II and ischemic heart disease, both presumed to be due to exposure to herbicide agents during the Veteran's active duty in Vietnam.

The Board remands the claims for service connection and special monthly compensation based on need for regular aid and attendance due to missing or newly discovered relevant official service department records that existed but were not associated with the claims file when previous rating decisions were issued, as well as potential clear and unmistakable error in those decisions.

The Board denied service connection for a heart condition and remanded claims for diabetes mellitus, renal kidney failure, colitis, and high blood pressure as secondary to diabetes mellitus.

The Board denied the veteran's claims for increased ratings and earlier effective dates, finding that the evidence did not support higher ratings or earlier effective dates.

The Board granted an effective date of October 25, 2016, for the grant of service connection for diabetes mellitus and associated neurological disabilities, subject to the laws governing payment of monetary benefits.

The Board granted service connection for diabetes mellitus type II, erectile dysfunction, and diabetic peripheral neuropathy of both lower extremities, effective July 3, 2022.

The Board granted service connection for type II diabetes mellitus and liver disease, both on a substitution basis.

The Board granted the reopening of the claim for a left hip disability and a 20 percent rating for scars on the left knee, lower left leg, and distal end fibula. The other claims were remanded.

The Board granted service connection for ischemic heart disease, diabetes mellitus, and bilateral peripheral neuropathy in the upper and lower extremities, effective August 31, 2016.

The Board remands the claim for service connection of diabetes mellitus for additional development.

The Board denied service connection for diabetes, skin rash, and peripheral neuropathy of the bilateral upper and lower extremities as there was no evidence to support in-service herbicide exposure or a relationship between these conditions and the Veteran's military service.

The Board dismissed the claims for service connection for diabetes mellitus, right leg amputation, left leg amputation, and back disorder due to the Veteran's passing and the Appellant's decision not to seek substitution before the Court.

The Board denied the veteran's claims for survivor's pension, accrued benefits, and DIC under 38 U.S.C. § 1318 due to the appellant's countable income exceeding the applicable maximum annual pension rates, no unpaid VA benefits or pending claims at the time of death, and lack of service-connected disability rated totally disabling.

The Board remands the claims for service connection for diabetes mellitus, hemorrhoids, and bilateral knee osteoarthritis with patellar instability due to a pre-decisional duty to assist error.

The Board denied service connection for diabetes mellitus and remanded the claims for obstructive sleep apnea and gastroesophageal reflux disease (GERD) for further development.

The Board denied the veteran's claims for increased ratings and service connection, as well as remanded several issues for further development.

The Board denied the veteran's claims for an earlier effective date, service connection for lung cancer, and remanded claims for service connection for diabetes mellitus, type II, hypertension, and colon cancer.